Outcomes of patients diagnosed with chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation: Results from a tertiary care center | Zendy

Swe Mar Linn | Zendy; Ram Vasudevan Nampoothiri | Zendy; Carol Chen | Zendy; Ivan Pašić | Zendy; Zeyad AlShaibani | Zendy; Wilson Lam | Zendy; Arjun Law | Zendy; Fotios V. Michelis | Zendy; Dennis Dong Hwan Kim | Zendy; Armin Gerbitz | Zendy; Jeffrey H. Lipton | Zendy; Rajat Kumar | Zendy; Jonas Mattsson | Zendy; Auro Viswabandya | Zendy

Open Access

Outcomes of patients diagnosed with chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation: Results from a tertiary care center

Author(s) -

Swe Mar Linn,

Ram Vasudevan Nampoothiri,

Carol Chen,

Ivan Pašić,

Zeyad AlShaibani,

Wilson Lam,

Arjun Law,

Fotios V. Michelis,

Dennis Dong Hwan Kim,

Armin Gerbitz,

Jeffrey H. Lipton,

Rajat Kumar,

Jonas Mattsson,

Auro Viswabandya

Publication year - 2021

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2021.09.008

Subject(s) - medicine , hazard ratio , hematopoietic stem cell transplantation , chronic lymphocytic leukemia , transplantation , stem cell , single center , total body irradiation , surgery , leukemia , gastroenterology , oncology , chemotherapy , confidence interval , cyclophosphamide , biology , genetics

Allogeneic hematopoietic stem cell transplantation (allo-HCT) is currently the only curative treatment for patients with chronic lymphocytic leukemia (CLL).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research